AngioDynamics Cardiovascular

The Exhibit Hall is open at #SIR26TOR - stop by the AngioDynamics booth #523 today between 9:15 AM-3:15 PM to learn more about our Cardiovascular solutions. #AngioDynamics #Auryon #AngioVac #AlphaVac #SIR26TOR

We’re excited to see you at #SIR26TOR! Come by booth #523 between 9:15 AM-3:15 PM to see our AngioDynamics Cardiovascular solutions in action! RSVP to our Cardiovascular reception, TOMORROW 4/13 at the Ritz-Carlton Toronto: bit.ly/4dx2VwE UC/NA/SM/4298

Stop by booth #523 at #SIR to learn more about our innovative Cardiovascular solutions. Join us for our Cardiovascular reception on 4/13 at the Ritz-Carlton Toronto. RSVP now to secure your spot: bit.ly/4dx2VwE Risk info: bit.ly/3V7wxGc

The APEX-Return Study is a major clinical initiative from AngioDynamics CV, focused on advancing care for patients with acute PE. Led by PI's Dr. Sukhdeep Basra, and Dr. Peter Monteleone. Contact: medicalaffairs@angiodynamics.com Risk info: bit.ly/3V7wxGc

#SIR26TOR is right around the corner! Connect with us: - Arterials hands-on: 4/12 | 9:15-10:30 AM - Cardiovascular reception: 4/13 | 5:30-8:00 PM | Ritz-Carlton | RSVP here: bit.ly/4dx2VwE - Venous hands-on: 4/14 | 9:15-10:30 AM Risk info: bit.ly/3V7wxGc

Visit AngioDynamics, booth #523 at SIR 2026, to see our comprehensive Cardiovascular portfolio.. Plus, we’ll be hosting a Cardiovascular reception on 4/13 at the Ritz-Carlton Toronto. RSVP now to secure your spot: bit.ly/4dx2VwE Risk info: bit.ly/3V7wxGc

Congratulations to Dr. Wade Schmidt and the team at CentraCare - St. Cloud Hospital, first site activated and now actively enrolling patients for the APEX-Return Study. Learn More: bit.ly/41bSTJV/ Risk info: bit.ly/4mg2mI9

Congratulations to Dr. David Zlotnick and the team at Kaleida Health – Buffalo General, for successfully enrolling and treating the first patient as part of the APEX-Return Study. Learn more: bit.ly/4tiCjUO Risk info: bit.ly/3V7wxGc

Join us at OEIS 2026! Visit the Auryon team at Booth 309. Learn more about the Auryon System ▶️ bit.ly/47aRiYV #AngioDynamics #Auryon #TheAuryonSystem Risk Info: bit.ly/3IOQLC2

Call for applications! ✍️ AngioDynamics invites qualified physicians to submit investigator-initiated research proposals related to pulmonary embolism (PE) and venous thromboembolic (VTE) disease. The ALPHA-PE RESEARCH FUND, sponsored by AngioDynamics in collaboration with the PERT Consortium, supports physicians dedicated to advancing research in PE. This research fund is designed to support independent, physician-led studies focused on improving real-world outcomes and advancing PE care. This innovative, evidence-based approach is a chance to shape the future of PE care. Learn more and apply to the ALPHA-PE RESEARCH FUND here: #submit-interest" target="_blank" rel="nofollow noopener">angiodynamics.com/alpha-pe-resea…

This March, AngioDynamics CV would like to recognize the importance of blood clot awareness month, #BCAM2026. We are proud to partner with the National Blood Clot Alliance. Learn more about our cardiovascular portfolio at: bit.ly/4aBc7P9

Navigate with confidence using the AlphaVac F18-85 System, purpose-built to deliver control, precision, and safety during #PE interventions. Learn more: bit.ly/4aBc7P9 Risk info: bit.ly/3V7wxGc Dr. Serhal is a paid consultant of AngioDynamics.

Join us at #ISETWeek2026 We look forward to an engaging event with expert clinical and scientific perspectives, interactive sessions, and meaningful insights.Visit the Auryon team at Booth 207. #AngioDynamics #Auryon Risk Info: bit.ly/3IOQLC2

Hands-on learning takes center stage at the 2026 #CVSF with our Thrombectomy and Atherectomy Workshops. Learn more: bit.ly/4aBc7P9 US/NA/SM/4144 Rev. 01 02/2026

Thank you to all participants who submitted a pitch at #CVSF2026. We would like to congratulate the winner, Dr. Juma Bin Firos, we can’t wait to see what’s ahead. Learn more about AngioDynamics Cardiovascular: bit.ly/4aBc7P9 US/NA/SM/4144 Rev. 01 02/2026

CVSF 4 is headed to Boston, bringing together the hands and hearts that lead in CV care for a focused weekend of clinical exchange, real-world insights, and connection with peers. Save the date—more details coming soon. bit.ly/4aBc7P9 bit.ly/3V7wxGc

Great CV care isn’t just about what happens in the procedure room—it’s also about collaboration and economics. #CVSF2026 Learn more: bit.ly/4aBc7P9 All physicians mentioned are paid consultants of AngioDynamics.

We would like to thank Dr. Patrick Muck and Dr. Sripal Bagalore for delivering an inspiring keynote address at the 2026 CVSF 🫀 Learn more: bit.ly/4aBc7P9 All physicians mentioned are paid consultants of AngioDynamics. US/NA/SM/4144 Rev. 01 02/2026

The 2026 #CVSF officially kicks off tonight. We’re bringing together leading clinicians, researchers, and innovators to explore the latest technologies shaping the future of cardiovascular care. Learn more about AngioDynamics Cardiovascular: bit.ly/4aBc7P9

“Pulmonary embolism continues to be a leading cause of morbidity and mortality across Europe, underscoring the need for treatment strategies that are both safe and effective.” Erik Klok, MD ▶️ bit.ly/4nvNdE1 #RECOVER-AV #AlphaVac #PE Risk: bit.ly/3UFe4Rf